ECRAID-Base Launches European Clinical Research Alliance

Read more

ECRAID-Base

Launches European Clinical Research Alliance

Utrecht, Wednesday February 24 - Following the signing of the Grant Agreement by the European Commission, COMBACTE is happy to announce that a funding of 30 million euros has been granted for ECRAID-Base, which will commence on March 1st 2021. In July 2020 we informed you about the submission of the European Clinical Research Alliance on Infectious Diseases (ECRAID)-Base proposal. ECRAID-Base is the initial set of activities for ECRAID. Over the five year duration of ECRAID-Base, ECRAID will evolve into a self-sustainable non-for-profit organization. 

Read press release

COMBACTE’s existing clinical and laboratory networks CLIN-Net and LAB-Net will be at the core of ECRAID-Base, and will continue to expand and play an important role in our future.

ECRAID-Base is the unification of several networks into one central sustainable infrastructure. The networks built by COMBACTE and PREPARE will allow running clinical research faster, easier, and more cost-effective. Pooling our forces, knowledge and expertise will help tackle the most urgent healthcare threats.

At the heart of ECRAID-Base are six perpetual studies. All will mature towards adaptive platform trials, with capability to rapidly respond to public health threats. One such platform is REMAP-CAP which was adapted to include COVID-19 treatment domains within two months after the outbreak.

ECRAID-Base Press Release
  • ECRAID aspires to become the first clinical research network of its kind in Europe, to offer a single point of access to a pan-European clinical research network for infectious diseases.

the need of a clinical research

Securing this funding is the European Union's testimonial in recognizing the need of a clinical research alliance like ECRAID-Base. We are very proud to have the infrastructure that COMBACTE has built over the last eight years, and we are looking ahead to many more.